Investors bought shares of Metlife Inc (NYSE:MET) on weakness during trading hours on Thursday. $108.12 million flowed into the stock on the tick-up and $56.22 million flowed out of the stock on the tick-down, for a money net flow of $51.90 million into the stock. Of all stocks tracked, Metlife had the 30th highest net in-flow for the day. Metlife traded down ($2.40) for the day and closed at $43.76
Several research analysts have weighed in on the company. B. Riley dropped their price target on Metlife from $58.00 to $50.00 and set a “neutral” rating for the company in a research note on Monday, July 16th. Zacks Investment Research downgraded Metlife from a “buy” rating to a “hold” rating in a research note on Tuesday, July 3rd. Credit Suisse Group dropped their price target on Metlife from $67.00 to $63.00 and set an “outperform” rating for the company in a research note on Friday, August 17th. Morgan Stanley dropped their price target on Metlife from $53.00 to $52.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 11th. Finally, Wells Fargo & Co restated a “buy” rating and issued a $60.00 price target on shares of Metlife in a research note on Thursday, September 27th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $55.00.
The company has a quick ratio of 0.15, a current ratio of 0.15 and a debt-to-equity ratio of 0.29. The stock has a market cap of $46.48 billion, a P/E ratio of 9.74, a P/E/G ratio of 0.71 and a beta of 1.23.
In other news, Chairman Steven A. Kandarian sold 85,683 shares of the stock in a transaction that occurred on Tuesday, August 21st. The stock was sold at an average price of $46.93, for a total transaction of $4,021,103.19. Following the completion of the transaction, the chairman now directly owns 585,005 shares in the company, valued at approximately $27,454,284.65. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Chairman Steven A. Kandarian sold 42,805 shares of the stock in a transaction that occurred on Monday, August 27th. The shares were sold at an average price of $47.03, for a total value of $2,013,119.15. Following the transaction, the chairman now owns 559,097 shares of the company’s stock, valued at $26,294,331.91. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by corporate insiders.
A number of institutional investors and hedge funds have recently modified their holdings of MET. Mount Yale Investment Advisors LLC bought a new stake in Metlife in the first quarter worth $108,000. Kaizen Advisory LLC lifted its position in Metlife by 148.0% in the second quarter. Kaizen Advisory LLC now owns 2,515 shares of the financial services provider’s stock worth $110,000 after buying an additional 1,501 shares during the last quarter. Flagship Harbor Advisors LLC bought a new stake in Metlife in the second quarter worth $110,000. FNY Investment Advisers LLC bought a new stake in Metlife in the second quarter worth $112,000. Finally, LFA Lugano Financial Advisors SA bought a new stake in Metlife in the second quarter worth $130,000. Institutional investors own 77.47% of the company’s stock.
Metlife Company Profile (NYSE:MET)
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Read More: What is a Leveraged Buyout (LBO)?
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.